Key facts
- Nature's Toolbox’s last known valuation is $71.0M (Feb 2026).
- It has raised $85.9M across 5 recorded rounds; the latest was Early Stage VC ($10.4M) in Nov 2025.
- Notable investors include RA Capital Management, Anzu Partners, BlueStone Venture Partners, Camino Real Capital Partners, High Desert Discovery District — 10 tracked in total.
- Nature's Toolbox has filed 4 Form Ds with the SEC since 2020, most recently May 2025 ($4.2M sold to 14 investors).
- Status: Privately Held (backing).
Investors
10- ·Post-money valuations for all 5 rounds
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Nature's Toolbox
Funding rounds
5 roundsAbout Nature's Toolbox
Developer of a scalable biomanufacturing platform designed to transform the healthcare industry through eco-friendly production of lifesaving therapies. The company's platform offers adaptable systems for personalized and large-scale therapy production to create life-saving medicines in an eco-friendly and sustainable way, enabling oncology, rare disease and other therapeutic fields to access efficient and sustainable biomanufacturing.
- Industry
- Discovery Tools (Healthcare)
- Sector
- Healthcare
- HQ
- Rio Rancho, NM, United States
- Founded
- 2015
- Employees
- 47
- Website
- ntxbio.com/
- Ownership
- Privately Held (backing)
Nature's Toolbox doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nature's Toolbox shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nature's Toolbox in its N-PORT filings yet. We sweep new filings monthly.